Patents by Inventor Eva KEILHAUER

Eva KEILHAUER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABLE LIQUID FORMULATIONS OF GLUCAGON-LIKE PEPTIDE 1 OR ANALOGUES THEREOF
    Publication number: 20240293515
    Abstract: Stable liquid formulations of GLP-1 and GLP-1 analogues and method of using such formulations in the treatment of disorders or conditions are provided.
    Type: Application
    Filed: May 13, 2024
    Publication date: September 5, 2024
    Applicant: Rose Pharma Inc.
    Inventors: Andrea HAWE, Eva KEILHAUER, Olimpia POPKO, Enda KENNY, Richard WARBURG
  • Methods of treatment with stable liquid formulations of glucagon-like peptide 1 or analogues thereof
    Patent number: 11980655
    Abstract: Stable liquid formulations of GLP-1 and GLP-1 analogues and method of using such formulations in the treatment of disorders or conditions are provided.
    Type: Grant
    Filed: May 28, 2021
    Date of Patent: May 14, 2024
    Assignee: Rose Pharma Inc.
    Inventors: Andrea Hawe, Eva Keilhauer, Olimpia Popko, Enda Kenny, Richard Warburg
  • STABLE LIQUID FORMULATIONS OF GLUCAGON-LIKE PEPTIDE 1 OR ANALOGUES THEREOF
    Publication number: 20210283226
    Abstract: Stable liquid formulations of GLP-1 and GLP-1 analogues and method of using such formulations in the treatment of disorders or conditions are provided.
    Type: Application
    Filed: May 28, 2021
    Publication date: September 16, 2021
    Applicant: Rose Pharma LLC
    Inventors: Andrea HAWE, Eva KEILHAUER, Olimpia POPKO, Enda KENNY, Richard WARBURG
  • Stable liquid formulations of glucagon-like peptide 1 or analogues thereof
    Patent number: 11058748
    Abstract: Stable liquid formulations of GLP-1 and GLP-1 analogues and method of using such formulations in the treatment of disorders or conditions are provided.
    Type: Grant
    Filed: December 2, 2020
    Date of Patent: July 13, 2021
    Assignee: Rose Pharma LLC
    Inventors: Andrea Hawe, Eva Keilhauer, Olimpia Popko, Enda Kenny, Richard Warburg
  • STABLE LIQUID FORMULATIONS OF GLUCAGON-LIKE PEPTIDE 1 OR ANALOGUES THEREOF
    Publication number: 20210169987
    Abstract: Stable liquid formulations of GLP-1 and GLP-1 analogues and method of using such formulations in the treatment of disorders or conditions are provided.
    Type: Application
    Filed: December 2, 2020
    Publication date: June 10, 2021
    Applicant: Rose Pharma LLC
    Inventors: Andrea HAWE, Eva KEILHAUER, Olimpia POPKO, Enda KENNY, Richard WARBURG